Skip to search.
 FTSE 100 Down 0.11%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
17.83 Up 0.64(3.72%) 3 Aug 21:00
|After Hours: : 17.83 0.00 (0.00%) 3 Aug 22:40
Add to Portfolio
Prev Close:17.19
Open:17.36
Bid:17.26 x 1000
Ask:19.88 x 200
1y Target Est:16.50
Beta:2.07
Next Earnings Date: 5-Aug-15FOLD Earnings announcement
Day's Range:17.30 - 17.91
52wk Range:3.96 - 17.91
Volume:1,826,169
Avg Vol (3m):2,049,150
Market Cap:2.07b
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FOLDUp 3.72%2.07b
SHPGUp 0.48%52.77b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,158.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.05
Quarterly EPS Est (Jun-15) :-0.24
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback